1 documents found
Information × Registration Number 0104U006507, R & D request Title Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo- controlled parallel group, 26 week study to asses the safety and efficacy of the humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed at weeks 0, 2, 4 then 4-weekly to week 24), in the treatmenr of patients with active Crohn's diseases" to be conducted according to Protocol Number CDP870-031 Head Захараш Михайло Петрович, Registration Date 27-05-2004 Organization Bogomolets National Medical University, Ministry of Health of Ukraine popup.description1 popup.nrat_date 2024-12-11 Close
search.res_rk
Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo- controlled parallel group, 26 week study to asses the safety and efficacy of the humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed at weeks 0, 2, 4 then 4-weekly to week 24), in the treatmenr of patients with active Crohn's diseases" to be conducted according to Protocol Number CDP870-031
Head: Захараш Михайло Петрович. Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo- controlled parallel group, 26 week study to asses the safety and efficacy of the humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed at weeks 0, 2, 4 then 4-weekly to week 24), in the treatmenr of patients with active Crohn's diseases" to be conducted according to Protocol Number CDP870-031. Bogomolets National Medical University, Ministry of Health of Ukraine. № 0104U006507
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку